全文获取类型
收费全文 | 1576篇 |
免费 | 95篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 49篇 |
妇产科学 | 204篇 |
基础医学 | 179篇 |
口腔科学 | 35篇 |
临床医学 | 226篇 |
内科学 | 198篇 |
皮肤病学 | 17篇 |
神经病学 | 44篇 |
特种医学 | 140篇 |
外科学 | 224篇 |
综合类 | 46篇 |
一般理论 | 1篇 |
预防医学 | 110篇 |
眼科学 | 2篇 |
药学 | 65篇 |
中国医学 | 2篇 |
肿瘤学 | 142篇 |
出版年
2021年 | 17篇 |
2018年 | 15篇 |
2016年 | 13篇 |
2015年 | 18篇 |
2014年 | 24篇 |
2013年 | 32篇 |
2012年 | 42篇 |
2011年 | 46篇 |
2010年 | 27篇 |
2009年 | 32篇 |
2008年 | 43篇 |
2007年 | 59篇 |
2006年 | 59篇 |
2005年 | 43篇 |
2004年 | 40篇 |
2003年 | 64篇 |
2002年 | 40篇 |
2001年 | 44篇 |
2000年 | 58篇 |
1999年 | 49篇 |
1998年 | 43篇 |
1997年 | 37篇 |
1996年 | 44篇 |
1995年 | 41篇 |
1994年 | 33篇 |
1993年 | 26篇 |
1992年 | 44篇 |
1991年 | 49篇 |
1990年 | 44篇 |
1989年 | 41篇 |
1988年 | 39篇 |
1987年 | 41篇 |
1986年 | 39篇 |
1985年 | 32篇 |
1984年 | 19篇 |
1983年 | 26篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 14篇 |
1979年 | 19篇 |
1978年 | 18篇 |
1977年 | 22篇 |
1976年 | 27篇 |
1975年 | 24篇 |
1974年 | 28篇 |
1973年 | 20篇 |
1972年 | 12篇 |
1970年 | 15篇 |
1969年 | 12篇 |
1968年 | 14篇 |
排序方式: 共有1686条查询结果,搜索用时 15 毫秒
101.
102.
103.
An evidence-based specialist breast nurse role in practice: a multicentre implementation study 总被引:4,自引:0,他引:4
Liebert B Parle M Roberts C Redman S Carrick S Gallagher J Simpson J Ng K Khan MA White K Salkeld G Lewis M Olver I Gill G Marchant M Coates A North R Akers G Cannon A Gray C Liebelt J Rodger A Henderson M Stoney D Hickey P Archer S Metcalf C Trotter J;National Breast Cancer Centre's Specialist Breast Nurse Project Team 《European journal of cancer care》2003,12(1):91-97
The objective of this study was to examine the feasibility, implementation, acceptability and impact of an evidence-based specialist breast care nurse (SBN) model of care in Australia. Primary data were collected from four diverse Australian breast cancer treatment centres over a 12-month period. The design was a multicentre demonstration project. Information about the provision of care and patient needs was collected through prospective logs. Structured interviews were conducted with women who received the SBN intervention ( N = 167) and with a control group of women treated prior to the intervention period ( N = 133). Health professionals ( N = 47) were interviewed about their experience of the SBN. Almost all women had contact with an SBN at five scheduled consultations and 67% of women in the intervention group requested at least one additional consultation with the SBN. Women in the intervention group were more likely to receive hospital fact sheets and to be told about and participate in clinical trials. Ninety-eight per cent of women reported that the availability of an SBN would affect their choice of hospital, with 48% indicating that they would recommend only a hospital with a SBN available. Health professionals reported that SBNs improved continuity of care, information and support for the women, and resulted in more appropriate referrals and use of the time of other members of the team. In conclusion, the SBN model is feasible and acceptable within diverse Australian treatment centres; there is evidence that some aspects of care were improved by the SBN. 相似文献
104.
While methadone is currently the primary pharmacotherapy used in the treatment of heroin dependence in Australia, levo-alpha-acetyl-methodol (LAAM) and buprenorphine are new pharmacotherapies that are being examined as alternatives to methadone maintenance treatment. The aim of this research is to consider the effects of the methadone, buprenorphine and LAAM, as used in maintenance pharmacotherapy for heroin dependence, upon simulated driving. Clients stabilised in methadone, LAAM and buprenorphine treatment programs for 3 months, and a control group of non-drug-using participants, took part in this study which involved operating a driving simulator over a 75 min period. All participants attended one session without alcohol and one session with alcohol at around the 0.05% blood alcohol level. Simulated driving skill was measured through standard deviations of lateral position, speed and steering wheel angle, and reaction time to a subsidiary task was also measured. While alcohol impaired all measures of driving performance, there were no differences in driving skills across the four participant groups. These findings suggest that typical community standards around driving safety should be applied to clients stabilised in methadone, LAAM and buprenorphine treatment. The findings are important in terms of the widespread implementation of these treatment options in Victoria given that a large proportion of pharmacotherapy clients drive. 相似文献
105.
Butler MW Mullan RH Schaffer KE Crotty TB Luke DA Donnelly SC 《Irish journal of medical science》2003,172(4):204-205
Background Hydatid disease is rare in Ireland and its incidence and prevalence are unknown. Most cases are diagnosed by a combination
of clinical findings, morphological features on imaging and by serological testing.
Aims We describe an Irish case of pulmonary hydatid disease detected at bronchoscopy by bronchoalveolar lavage, and discuss the
diagnosis and treatment of the disorder. 相似文献
106.
Chromium as adjunctive treatment for type 2 diabetes 总被引:1,自引:0,他引:1
OBJECTIVE: To review the chemistry, pharmacology, efficacy, and safety of trivalent chromium in the treatment of type 2 diabetes and hyperlipidemia. DATA SOURCES: The English literature was searched from 1966 through May 2002 using MEDLINE, International Pharmaceutical Abstracts, and EMBASE. The key words included chromium, glucose, lipids, and diabetes. Pertinent references from review articles and studies were used as additional sources. DATA SYNTHESIS: Trivalent chromium is an essential nutrient and has a key role in lipid and glucose metabolism. Supplementation with chromium does not appear to reduce glucose levels in euglycemia. It may, however, have some efficacy in reducing glucose levels in hyperglycemia. The effects of chromium on lipid levels are variable. Chromium in doses <1000 microg/d appears to be safe for short-term administration. Kidney function and dermatologic changes need to be monitored. CONCLUSIONS: Chromium appears to be a safe supplement and may have a role as adjunctive therapy for treatment of type 2 diabetes. Additional large-scale, long-term, randomized, double-blind studies examining the effect of various doses and forms of chromium are needed. 相似文献
107.
The aims of this study were to identify (1) the ethics and human rights issues experienced by nurses in leadership roles (NLs); (2) how frequently these issue occurred in the NLs'practices; and (3) how disturbed the NLs were by the issues. Dillman's Total Design Method (1978) for mailed surveys guided the study design. Data analysis was performed on 470 questionnaires from New England RNs in nursing leadership roles. The most frequently experienced ethics and human rights issues during the previous 12 months were (1) protecting patient right and human dignity; (2) respecting or not respecting informed consent to treatment; (3) use or nonuse of physical or chemical restraints; (4) providing care with possible risks to the RN's health; (5) following or not following advance directives; and (6) staffing patterns that limit patient access to nursing care. The most disturbing ethics and human rights issues experienced by the NLs were staffing patterns that limited patient access to nursing care, prolonging the dying process with inappropriate measures, working with unethical, incompetent, or impaired colleagues, implementing managed care policies that threaten quality of care, not considering quality of the patient's life, and caring for patients and families who are uninformed or misinformed about treatment, prognosis, or medical alternatives. Nearly 39% of the NLs reported experiencing ethics and human rights issues one to four times a week or more, and more than 90% handled their most recent ethics issue by discussing it with nursing peers. Study findings have implications for ethics education and resource support for nurses in leadership roles, and for further research on how NLs handle ethics and human rights issues in the workplace. 相似文献
108.
109.
110.
The Coalition of Allied Health Leadership (CAHL) 2000 Representation Team sought 1) to secure Federal advisory appointments for allied health professionals and 2) to connect allied health representatives with Federal advisory committees, councils, boards, and other deliberative bodies. Among the deliberative bodies providing recommendations on a broad range of issues to the President of the United States and the Executive Branch, there are over 1,000 advisory committees, councils, and boards, with more than 20,000 members. Recommendations made by the deliberative bodies include those related to health care. The literature and Web sites reveal allied health professionals have little or no representation on the bodies that represent allied health professionals and their constituents. These findings provide insights into Federal-level deliberative bodies to which allied health professionals have access or on which they warrant representation. This article reports background information, including the CAHL 2000 Representation Team objectives; an overview of federal advisory committees; recommendations for gaining access to deliberative bodies and active participation in fulfillment of Healthy People 2010 goals; and continued commitment to such representation by the CAHL and allied health professionals. 相似文献